Pharma Research Products 파마리서치프로덕트, a regenerative medicine company, said Thursday that it has released “Rejuran Healer Turnover Ampoule®,” a premium home care cosmetics.
The cosmetic’s core component is c-PDRN®, an ingredient based on the company’s patented technology of DOT™, which optimizes DNA.
The ampoule is a product highly concentrated with c-PDRN® compared to the original Rejuran®, used by dermatologists, making them easier to be absorbed by the skin.
c-PDRN® is a DNA component that promotes skin's improvement and heals skin, wrinkles and elasticity damage from the external environment. It also normalizes the skin regeneration cycle to return the skin to a healthier state.
Through 15 clinical tests, the product proved to improve skin texture, skin tone, and skin and gave rapid reversal effects to damaged skin.
“We are excited to announce the expansion of our Derma cosmetic lineup, which uses our regenerative medicine patent technology,” a company official said.
Pharma Research's products are widely available at home and abroad, including PDRN® component tissue regeneration ingredients, PN-component medical devices, and c-PDRN® cosmetic products.
<© Korea Biomedical Review, All rights reserved.>